Geographic and Temporal Patterns of Antimicrobial Resistance in
Pseudomonas aeruginosa
antimicrobial
multidrug resistance
surveillance
susceptibility
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
22
3
2019
Statut:
epublish
Résumé
The SENTRY Antimicrobial Surveillance Program was established in 1997 and encompasses over 750 000 bacterial isolates from ≥400 medical centers worldwide. Among the pathogens tested, From 1997 to 2016, 52 022 clinically significant consecutive isolates were submitted from ≥200 medical centers representing the Asia-Pacific region, Europe, Latin America, and North America. Only 1 isolate per patient per infection episode was submitted. Isolates were identified by standard algorithms and/or matrix-assisted laser desorption ionization-time of flight mass spectrometry. Susceptibility testing was performed by Clinical and Laboratory Standards Institute (CLSI) methods and interpreted using CLSI and European Committee on Antimicrobial Susceptibility Testing 2018 criteria at JMI Laboratories. The most common infection from which Over the 20 years of SENTRY Program surveillance, the rate of MDR
Sections du résumé
BACKGROUND
BACKGROUND
The SENTRY Antimicrobial Surveillance Program was established in 1997 and encompasses over 750 000 bacterial isolates from ≥400 medical centers worldwide. Among the pathogens tested,
METHODS
METHODS
From 1997 to 2016, 52 022 clinically significant consecutive isolates were submitted from ≥200 medical centers representing the Asia-Pacific region, Europe, Latin America, and North America. Only 1 isolate per patient per infection episode was submitted. Isolates were identified by standard algorithms and/or matrix-assisted laser desorption ionization-time of flight mass spectrometry. Susceptibility testing was performed by Clinical and Laboratory Standards Institute (CLSI) methods and interpreted using CLSI and European Committee on Antimicrobial Susceptibility Testing 2018 criteria at JMI Laboratories.
RESULTS
RESULTS
The most common infection from which
CONCLUSIONS
CONCLUSIONS
Over the 20 years of SENTRY Program surveillance, the rate of MDR
Identifiants
pubmed: 30895216
doi: 10.1093/ofid/ofy343
pii: ofy343
pmc: PMC6419917
doi:
Types de publication
Journal Article
Langues
eng
Pagination
S63-S68Références
J Antimicrob Chemother. 2003 Oct;52(4):699-702
pubmed: 12951331
J Antimicrob Chemother. 2005 Jul;56(1):122-7
pubmed: 15890715
Antimicrob Agents Chemother. 2009 Sep;53(9):3908-13
pubmed: 19596871
Clin Microbiol Rev. 2009 Oct;22(4):582-610
pubmed: 19822890
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Antimicrob Agents Chemother. 2012 Sep;56(9):4833-7
pubmed: 22751533
J Antimicrob Chemother. 2013 Dec;68(12):2820-4
pubmed: 23843299
J Antimicrob Chemother. 2014 Jul;69(7):1804-14
pubmed: 24603963
Antimicrob Agents Chemother. 2014 Nov;58(11):6844-50
pubmed: 25182652
Crit Care. 2014 Nov 21;18(6):596
pubmed: 25412897
Drug Resist Updat. 2015 Jul-Aug;21-22:41-59
pubmed: 26304792
Mem Inst Oswaldo Cruz. 2016 Sep;111(9):551-8
pubmed: 27653359
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7216-7223
pubmed: 27671068
Braz J Infect Dis. 2017 Jan - Feb;21(1):57-62
pubmed: 27916604
Front Microbiol. 2016 Dec 05;7:1946
pubmed: 27994579
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28483953
N Engl J Med. 2017 Jun 8;376(23):2235-2244
pubmed: 28528569
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28827415
Int J Antimicrob Agents. 2018 Feb;51(2):181-189
pubmed: 28993143